Literature DB >> 7924853

Pathologic scotopization: a shortened Nagel-II anomaloscopic micro-screw method.

A Pinckers1.   

Abstract

The Nagel-II micro-screw method uses eleven colour equations between 620 and 560 nm. The luminance settings are given and are based on the data of colour normal individuals. In the shortened version, intended to detect pathologic scotopization, it is ascertained at which position of the micro-screw the patient's colour adjustments drop beneath the level of 60 scale Units. A total of 64 patients was examined. 29 congenital colour defectives and 35 acquired colour defectives. With the shortened micro-screw method the patients can be divided into four groups: (1) a group without pathologic scotopization, which includes congenital protan defectives: (2) a group in which pathologic scotopization starts; (3) a group with evident pathologic scotopization, due to Stargardt's disease and other cone dystrophies; and (4) a group with complete pathologic scotopization, which includes the congenital achromats and the end-stages of the cone dystrophies.

Entities:  

Mesh:

Year:  1994        PMID: 7924853     DOI: 10.1007/bf01664933

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  5 in total

1.  Further studies on acquired deficiency of color discrimination.

Authors:  G VERRIEST
Journal:  J Opt Soc Am       Date:  1963-01

2.  Scotopization and the Nagel-II anomaloscope.

Authors:  A Pinckers; M Marre
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

3.  Influence of pathologic scotopization on the extended Rayleigh match.

Authors:  M Marré; A Pinckers
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Color vision and age.

Authors:  A Pinckers
Journal:  Ophthalmologica       Date:  1980       Impact factor: 3.250

5.  Scotopization and pseudoprotanomaly in blue-yellow/colour vision defects.

Authors:  A Pinckers; M Marré
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.